Showing results (541-550 of 579) with videos related to
Sort By:
Pageof 58
Cytokine & Growth Factor Reviews|December 22, 2019
Anticancer innovative therapy: Highlights from the ninth annual meetingT Volpari, F De Santis, A P Bracken, et al.The American Journal of Pathology|December 23, 2014
Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondriaGabriele Di Sante, Timothy G Pestell, Mathew C Casimiro, et al.Biochemistry|December 24, 2003
Caveolin-1 null (-/-) mice show dramatic reductions in life spanDavid S Park, Alex W Cohen, Philippe G Frank, et al.Cell Cycle (Georgetown, Tex.)|May 28, 2013
Caloric restriction augments radiation efficacy in breast cancerAnthony D Saleh, Brittany A Simone, Juan Palazzo, et al.Cell Cycle (Georgetown, Tex.)|November 6, 2010
The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradoxUbaldo E Martinez-Outschoorn, Diana Whitaker-Menezes, Stephanos Pavlides, et al.The American Journal of Pathology|September 14, 2025
Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor-Positive Breast Cancer CellsFelice M Accattatis, Luca Gelsomino, Linda Manna, et al.Cancer Biology & Therapy|May 7, 2008
Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapyIsabelle Mercier, Mathew C Casimiro, Chenguang Wang, et al.Nature Genetics|September 5, 2006
Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataractFederico Zara, Roberta Biancheri, Claudio Bruno, et al.The Journal of Biological Chemistry|July 18, 2001
Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalitiesB Razani, J A Engelman, X B Wang, et al.Cell Cycle (Georgetown, Tex.)|April 7, 2011
Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cellsMilena B P Soares, Ricardo S Lima, Bruno S F Souza, et al.Pageof 58